2025 Subcommittee on Psychopharmacology
The Subcommittee on Psychopharmacology is a weekly meeting of all prescribing psychiatric staff. The committee serves to support and educate psychiatrists in work with complicated and generally “treatment-resistant” patients. The committee offers participating psychiatrists an opportunity to present clinical and countertransference challenges and to benefit from an educational and transferential “Third” to the doctor-patient pair. The committee serves a peer review function, in evaluating the treatment of patients prior to Case Conferences in the light of the standard of care, institutional priorities, performance improvement, and the principles of psychodynamic psychopharmacology. The committee also focuses on risk management and serves to review negative outcomes and near misses, incorporating PI methodologies such as Fishbone and Failure Mode Effects Causal Analysis. The committee will work directly with patients and their prescribers, in order to address and ameliorate treatment impasses in psychopharmacology. The committee also serves as an opportunity to disseminate recent developments in psychopharmacology, including new evidence, changes in the standard of practice, and new drug warnings. The committee interfaces with other systems within the treatment environment, including the medical office, the nursing department, information technology, and the pharmacy. In these interdepartmental engagements, the committee explores and evaluates systems-based practices in the service of education and performance improvement.
Target Audience
MD and DO
Learning Objectives
1. Review important evidence -based findings in psychopharmacology and relevant drug warnings (eg, from the FDA).
2. Assess current (individual and group) psychiatric practice patterns in the context of the standard of care and new evidence.
3. Integrate evidence on psychosocial/psychodynamic aspects of prescribing process.
4. Investigate institutional systems for delivery of pharmacologic care (including informatics) for system improvemen
John Azer, MD
Marina Bayeva, MD
Vivian Chan, DO
Heather Forouhar, MD
Samar Habl, MD
Nick Holiday, MD
David Mintz, MD
Kyle Shepard, DO
Margaret Parish, PhD
Gabriel Jimenez, MD
Edward Shapiro, MD
Available Credit
- 30.00 AMA PRA Category 1 Credit™
ACCME - As a Jointly Accredited Organization, The Austen Riggs Center, Inc. designates this learning activity for a maximum of 30.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Facebook
X
LinkedIn
Forward